Nexlizet Tablet, Film Coated
Product Images NDC 72426-818

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nexlizet (NDC 72426-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Esperion Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nexlizet 01)

Chemical structure of Bempedoic Acid, the active ingredient in Nexlizet. The diagram shows the molecular arrangement including hydroxyl and carboxyl functional groups.*

FDA Label Image

Chemical Structure (Nexlizet 02)

Chemical structure of Bempedoic Acid, the active ingredient in Nexlizet tablets. The diagram shows the molecular arrangement including fluorine (F), sulfur (S), oxygen (O), and hydrogen (H) atoms in the compound.*

FDA Label Image

Principal Display Panel (180 mg/10 mg Tablet Bottle Label)

Label for Nexlizet tablets containing bempedoic acid 180 mg and ezetimibe 10 mg. The film-coated oral tablet packaging holds 30 tablets. Manufactured for Esperion Therapeutics, Inc., the label includes storage instructions, dosage information, and indicates the product is Rx only. The label also notes the country of origin for the active ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.